ALNYLAM PHARMACEUTICALS, INC. Net Change in Cash 2008-2025 | ALNY
Beta
What is net change in cash?
Net change in cash represents the total increase or decrease in cash and cash equivalents during the reporting period.
What is ALNYLAM PHARMACEUTICALS, INC.'s current net change in cash?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual net change in cash for 2025 was $690.2M, a 348.83% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. net change in cash for the quarter ending December 31, 2025 was $166.0M.
What was ALNYLAM PHARMACEUTICALS, INC.'s net change in cash in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual net change in cash for 2024 was $153.8M, a 386.50% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s net change in cash in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual net change in cash for 2023 was $-53.7M, a 215.66% decline from 2022.
Net Change in Cash History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-50.6M
→
FY2025
$690.2M
080910111213141516171819202122232425
5 years selected
Net Change in Cash History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $690.2M | +348.8% | 10-K |
| FY2024 | $153.8M | +386.5% | 10-K |
| FY2023 | $-53.7M | -215.7% | 10-K |
| FY2022 | $46.4M | -85.6% | 10-K |
| FY2021 | $323.1M | +738.8% | 10-K |
| FY2020 | $-50.6M | -139.8% | 10-K |
| FY2019 | $127.0M | +156.6% | 10-K |
| FY2018 | $-224.2M | -149.6% | 10-K |
| FY2017 | $451.7M | +3450.9% | 10-K |
| FY2016 | $12.7M | -88.0% | 10-K |
| FY2015 | $105.7M | +380.3% | 10-K |
| FY2014 | $22.0M | +1147.7% | 10-K |
| FY2013 | $1.8M | +109.4% | 10-K |
| FY2012 | $-18.8M | -330.6% | 10-K |
| FY2011 | $-4.4M | +93.0% | 10-K |
| FY2010 | $-62.9M | -15.7% | 10-K |
| FY2009 | $-54.3M | -162.7% | 10-K |
| FY2008 | $86.6M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →